141 related articles for article (PubMed ID: 37908943)
1. Serum Activities of Paraoxonase 1 (PON1) in Predicting Liver Damage Among Patients Diagnosed With Hepatocellular Carcinoma: A Case-Control Study.
Bade JD; Veeramalla V; Naidu MBR; Lalitha DL; Ponnada SC; Kandi V
Cureus; 2023 Sep; 15(9):e46234. PubMed ID: 37908943
[TBL] [Abstract][Full Text] [Related]
2. Serum Basal Paraoxonase 1 Activity as an Additional Liver Function Test for the Evaluation of Patients with Chronic Hepatitis.
Pyati AK; Halappa CK; Pyati SA; Nagaraj ; Wali V
J Clin Diagn Res; 2015 Nov; 9(11):BC12-5. PubMed ID: 26674516
[TBL] [Abstract][Full Text] [Related]
3. Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B.
Mogarekar MR; Talekar SJ
Indian J Gastroenterol; 2013 Sep; 32(5):307-10. PubMed ID: 23700138
[TBL] [Abstract][Full Text] [Related]
4. Serum paraoxonase-1 as biomarker for improved diagnosis of fatty liver in dairy cows.
Farid AS; Honkawa K; Fath EM; Nonaka N; Horii Y
BMC Vet Res; 2013 Apr; 9():73. PubMed ID: 23578174
[TBL] [Abstract][Full Text] [Related]
5. Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma.
Ding GY; Zhu XD; Ji Y; Shi GM; Shen YH; Zhou J; Fan J; Sun HC; Huang C
Ann Transl Med; 2020 Mar; 8(5):204. PubMed ID: 32309351
[TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage.
Ferré N; Camps J; Prats E; Vilella E; Paul A; Figuera L; Joven J
Clin Chem; 2002 Feb; 48(2):261-8. PubMed ID: 11805006
[TBL] [Abstract][Full Text] [Related]
7. Correlation of serum arylesterase activity on phenylacetate estimated by the integrated method to common classical biochemical indexes of liver damage.
Liao F; Zhu XY; Wang YM; Zhao YS; Zhu LP; Zuo YP
J Zhejiang Univ Sci B; 2007 Apr; 8(4):237-41. PubMed ID: 17444597
[TBL] [Abstract][Full Text] [Related]
8. Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity.
Keskin M; Dolar E; Dirican M; Kiyici M; Yilmaz Y; Gurel S; Nak SG; Erdinc S; Gulten M
Intern Med J; 2009 Apr; 39(4):243-8. PubMed ID: 19402863
[TBL] [Abstract][Full Text] [Related]
9. Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.
Zhang S; Jiang K; Zhang Q; Guo K; Liu Y
Glycoconj J; 2015 May; 32(3-4):119-25. PubMed ID: 25702281
[TBL] [Abstract][Full Text] [Related]
10. Serum arylesterase and paraoxonase activity in patients with chronic hepatitis.
Kilic SS; Aydin S; Kilic N; Erman F; Aydin S; Celik I
World J Gastroenterol; 2005 Dec; 11(46):7351-4. PubMed ID: 16437641
[TBL] [Abstract][Full Text] [Related]
11. Assessment of biochemical liver function tests in relation to age among steady state sickle cell anemia patients.
Akuyam SA; Abubakar A; Lawal N; Yusuf R; Aminu SM; Hassan A; Musa A; Bello AK; Yahaya IA; Okafor PA
Niger J Clin Pract; 2017 Nov; 20(11):1428-1433. PubMed ID: 29303127
[TBL] [Abstract][Full Text] [Related]
12. Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.
Liberopoulos EN; Papavasiliou E; Miltiadous GA; Cariolou M; Siamopoulos KC; Tselepis AD; Elisaf MS
Perit Dial Int; 2004; 24(6):580-9. PubMed ID: 15559488
[TBL] [Abstract][Full Text] [Related]
13. Serum paraoxonase 1 activity status in patients with liver disorders.
Kedage V; Muttigi MS; Shetty MS; Suvarna R; Rao SS; Joshi C; Prakash M
Saudi J Gastroenterol; 2010; 16(2):79-83. PubMed ID: 20339175
[TBL] [Abstract][Full Text] [Related]
14. Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment.
Marsillach J; Aragonès G; Mackness B; Mackness M; Rull A; Beltrán-Debón R; Pedro-Botet J; Alonso-Villaverde C; Joven J; Camps J
Lipids Health Dis; 2010 May; 9():46. PubMed ID: 20470383
[TBL] [Abstract][Full Text] [Related]
15. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
[TBL] [Abstract][Full Text] [Related]
16. Better performance of PIVKA-II for detecting hepatocellular carcinoma in patients with chronic liver disease with normal total bilirubin.
Qian XJ; Wen ZM; Huang XM; Feng HJ; Lin SS; Liu YN; Li SC; Zhang Y; Peng WG; Yang JR; Zheng ZY; Zhang L; Zhang DW; Lu FM; Liu LJ; Pan WD
World J Gastroenterol; 2023 Feb; 29(8):1359-1373. PubMed ID: 36925461
[TBL] [Abstract][Full Text] [Related]
17. Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.
AnandBabu K; Bharathidevi SR; Sripriya S; Sen P; Prakash VJ; Bindu A; Viswanathan N; Angayarkanni N
Exp Eye Res; 2016 Nov; 152():100-112. PubMed ID: 27693409
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of thiols, paraoxonase 1, arylesterase and oxidative balance in colorectal cancer in human.
Bulbuller N; Eren E; Ellidag HY; Oner OZ; Sezer C; Aydin O; Yılmaz N
Neoplasma; 2013; 60(4):419-24. PubMed ID: 23581414
[TBL] [Abstract][Full Text] [Related]
19. Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.
Lin YJ; Lee MH; Yang HI; Jen CL; You SL; Wang LY; Lu SN; Liu J; Chen CJ
PLoS One; 2013; 8(4):e61448. PubMed ID: 23613855
[TBL] [Abstract][Full Text] [Related]
20. [Clinical value of plasma scaffold protein SEC16A in evaluating hepatitis B-related liver cirrhosis and hepatocellular carcinoma].
Dong C; Chang CD; Zhao DD; Zhang XX; Guo PL; Dou Y; Zhao SX; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2023 Jun; 31(6):621-626. PubMed ID: 37400387
[No Abstract] [Full Text] [Related]
[Next] [New Search]
